跳至主要内容
临床试验/NCT02971800
NCT02971800已完成不适用

Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
1
主要终点
Quality of Ureteral Efflux Coloration With Sodium Fluorescein Collected With Dedicated Questionnaire

研究概览

简要总结

The primary objective is to describe the safety and efficacy of intravenous sodium fluorescein to visualize ureteral efflux during intraoperative cystoscopy after total laparoscopic hysterectomy. Secondary objective is to report on surgeon's satisfaction with the overall use of sodium fluorescein.

详细描述

Thirty patients (n=30) ongoing a total laparoscopic hysterectomy in a tertiary gynecological reference center will be included in this prospective descriptive study.Once hysterectomy is completed, a 10 % solution of sodium fluorescein at a 0,25 ml dose will be injected before performing diagnostic cystoscopy. Time from injection to fluorescent visualization will be recorded as well as coloration density. Adverse events are collected in the operating room, in the recovery room, before patient's discharge and through a home survey.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • total laparoscopic hysterectomy

排除标准

  • breastfeeding
  • renal insufficiency
  • Medication: Probenecid, digoxin, quinidine, beta-blocker
  • hypersensitivity or intolerance to sodium fluorescein

研究组 & 干预措施

sodium fluorescein

Experimental

Once hysterectomy completed, a 10 % solution of sodium fluorescein at a 0,25 ml dose (25 mg) is injected before performing diagnostic cystoscopy for all patient.

Name: Fluorescite Injection 10%, contains sodium fluorescein (equivalent to fluorescein 10% w/v) Dosage : 25 mg Frequency: only once

干预措施: sodium fluorescein injection 10% (Drug)

结局指标

主要结局

Quality of Ureteral Efflux Coloration With Sodium Fluorescein Collected With Dedicated Questionnaire

时间窗: within 15 minutes after the beginning of cystoscopy

Time of visualisation of turbulence, time of visualisation of coloration and quality of ureteral efflux coloration (clearly visible or somewhat visible or not visible)

Adverse Reaction Related to Sodium Fluorescein Injection

时间窗: From sodium fluorescein injection to follow-up 2 months after surgery

次要结局

  • Surgeon Satisfaction Regarding Ureteral Efflux Visualization by Filling Out a Dedicated Questionnaire(after cystoscopy (up to 15 min after injection))

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Philippe Y Laberge

Gynecologist

CHU de Quebec-Universite Laval

研究点 (1)

Loading locations...

相似试验